72 results on '"Ronsisvalle, Simone"'
Search Results
2. Harmaline and Human ClpP Activation for Pediatric Diffuse Intrinsic Pontine Glioma (DIPG) Treatment
3. Aerosol Emissions from Heated Tobacco Products: A Review Focusing on Carbonyls, Analytical Methods, and Experimental Quality
4. Evaluation of Crocin Content and In Vitro Antioxidant and Anti-Glycation Activity of Different Saffron Extracts
5. In Vitro Evaluation of Antioxidant and Anti-Glycation Activity of Crocin from Different Saffron Extracts
6. Aerosol emissions from Heated Tobacco Products: a review focusing on carbonyls, analytical methods and experimental quality
7. Aerosol emissions from Heated Tobacco Products: a review focusing on carbonyls, analytical methods and experimental quality
8. BS148 Reduces the Aggressiveness of Metastatic Melanoma via Sigma-2 Receptor Targeting
9. Different In Silico Approaches Using Heterocyclic Derivatives against the Binding between Different Lineages of SARS-CoV-2 and ACE2
10. Identification of a novel adiponectin receptor and opioid receptor dual acting agonist as a potential treatment for diabetic neuropathy
11. Chemical, Antioxidant and Biological Studies of Brassica incana subsp. raimondoi (Brassicaceae) Leaf Extract
12. Effects of Mangiferin on LPS-Induced Inflammation and SARS-CoV-2 Viral Adsorption in Human Lung Cells
13. Formulation of germinated brown rice fermented products functionalized by probiotics
14. Orobanche crenata Forssk. Extract Affects Human Breast Cancer Cell MCF-7 Survival and Viral Replication
15. Anti-Candidal Activity of the Parasitic Plant Orobanche crenata Forssk
16. Role of Iron Chelation and Protease Inhibition of Natural Products on COVID-19 Infection
17. Anti-malarial Drugs are Not Created Equal for SARS-CoV-2 Treatment: A Computational Analysis Evidence
18. Antimicrobial, Antioxidant, and Cytotoxic Activities of Juglans regia L. Pellicle Extract
19. Identification of a Potent and Selective 5-HT1A Receptor Agonist with In Vitro and In Vivo Antinociceptive Activity
20. Pharmacological properties and biochemical mechanisms of μ-opioid receptor ligands might be due to different binding poses: MD studies
21. Natural Flavones and Flavonols: Relationships among Antioxidant Activity, Glycation, and Metalloproteinase Inhibition
22. Quantum Chemical and Molecular Dynamics Studies of MUC1 Calix[4,8]arene Scaffold Based Anticancer Vaccine Candidates
23. Exploiting the 1-(4-fluorobenzyl)piperazine fragment for the development of novel tyrosinase inhibitors as anti-melanogenic agents: Design, synthesis, structural insights and biological profile
24. Antibacterial and anti-biofilm activities of walnut pellicle extract (Juglans regia L.) against coagulase-negative staphylococci
25. 1,3-Dioxane as a scaffold for potent and selective 5-HT1AR agonist with in-vivo anxiolytic, anti-depressant and anti-nociceptive activity
26. Mangifera indica L. Leaf Extract Induces Adiponectin and Regulates Adipogenesis
27. Molecular modeling and biological studies show that some μ-opioid receptor agonists might elicit analgesia acting as MMP-9 inhibitors
28. In vitro evaluation of biological activities of Orobanche crenata Forssk. leaves extract
29. Synthesis and Biological Evaluation of 1,3-dioxolane-based 5-HT 1A Receptor Agonists for CNS Disorders and Neuropathic Pain
30. Antioxidant and antimicrobial properties of Casteanea sativa Miller chestnut honey produced on Mount Etna (Sicily)
31. Structure–Activity Relationships within a Series of σ1 and σ2 Receptor Ligands: Identification of a σ2 Receptor Agonist (BS148) with Selective Toxicity against Metastatic Melanoma
32. Synthesis, biological evaluation and molecular modeling of 1-oxa-4-thiaspiro- and 1,4-dithiaspiro[4.5]decane derivatives as potent and selective 5-HT1A receptor agonists
33. An LP1 analogue, selective MOR agonist with a peculiar pharmacological profile, used to scrutiny the ligand binding domain
34. Evaluation of N-substituent structural variations in opioid receptor profile of LP1
35. Scouting new sigma receptor ligands: Synthesis, pharmacological evaluation and molecular modeling of 1,3-dioxolane-based structures and derivatives
36. DSC investigation of the effect of the new sigma ligand PPCC on DMPC lipid membrane
37. Differential scanning calorimetry approach to investigate the transfer of the multitarget opioid analgesic LP1 to biomembrane model
38. Steered Molecular Dynamics Simulations for Studying Protein–Ligand Interaction in Cyclin-Dependent Kinase 5
39. In Silico Modeling of the Immune System: Cellular and Molecular Scale Approaches
40. From NMDA receptor antagonists to discovery of selective σ2 receptor ligands
41. The antagonistic effect of the sigma 1 receptor ligand (+)-MR200 on persistent pain induced by inflammation
42. Erratum to: Effects of a Selective Sigma 1 Antagonist Compound on Inflammatory Pain
43. Optimization of Curcumin Loaded Lipid Nanoparticles Formulated Using High Shear Homogenization (HSH) and Ultrasonication (US) Methods
44. Effects of a Selective Sigma 1 Antagonist Compound on Inflammatory Pain
45. The multitarget opioid ligand LP1's effects in persistent pain and in primary cell neuronal cultures
46. 5-Arylidene-4-Thiazolidinone Derivatives Active as Antidegenerative Agents on Human Chondrocyte Cultures
47. 5-Arylidene-4-Thiazolidinone Derivatives Active as Antidegenerative Agents on Human Chondrocyte Cultures
48. Antinociceptive profile of LP1, a non-peptide multitarget opioid ligand
49. Effects of intraplantar Nocistatin and (±)-J 113397 injections on nociceptive behavior in a rat model of inflammation
50. The benzomorphan-based LP1 ligand is a suitable MOR/DOR agonist for chronic pain treatment
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.